Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel with reparixin vs placebo in metastatic triple-negative breast cancer; study completed with results post…
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer [Phase 3]
Phase 3 trial evaluating SHR6390 with letrozole or anastrozole in HR-positive, HER2-negative advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer [Phase 2]
Phase 2 trial update evaluating concomitant and sequential radiohormonotherapy in adjuvant breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN) [Phase 2]
Phase 2 trial comparing tyrosine kinase inhibitors versus pertuzumab in HER2-positive breast cancer with active brain metastases is ongoing …
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: The BEACON Study (Breast Cancer Outcomes With NKTR-102) [Phase 3]
Phase 3 BEACON study completed for NKTR-102 in locally recurrent and metastatic breast cancer; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-05-28FDA Approved: FULVESTRANT — Supplemental Application (Meitheal Pharmaceuticals Inc)
The FDA approved a supplemental application for fulvestrant from Meitheal Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2021-05-26Clinical Trial Update: The PIONEER-01 Study of the Imagio Breast Imaging System [NA]
Clinical trial update for the PIONEER-01 study of the Imagio Breast Imaging System has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast Cancer [Phase 2]
Phase 2 rollover study of weekly paclitaxel (BMS-181339) in advanced breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Pyrotinib Versus Pertuzumab in Combination With Neoadjuvant Trastuzumab and Nab-Paclitaxel in HER2+ Early or Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial comparing pyrotinib to pertuzumab, in combination with neoadjuvant trastuzumab and nab-paclitaxel, for HER2-positive early or …
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: S 81694 Plus Paclitaxel in Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial update for S 81694 combined with Paclitaxel in metastatic breast cancer and metastatic triple-negative breast cancer, complet…
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer [Phase 4]
Phase 4 trial evaluating rheumatologic effects of anastrozole and letrozole as adjuvant therapy in post-menopausal women with breast cancer;…
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer [Phase 3]
Phase 3 trial evaluating pyrotinib after adjuvant trastuzumab in women with early-stage breast cancer is ongoing; no results yet reported.
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: Eribulin Combined With Anlotinib in Metastatic HER2 Negative Breast Cancer [Phase 2]
A Phase 2 trial evaluating eribulin in combination with anlotinib for metastatic HER2-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer [Phase 3]
Phase 3 trial update evaluating letrozole for postmenopausal women with hormone receptor-positive breast cancer after prior hormone therapy.
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating tocotrienol in combination with neoadjuvant chemotherapy for breast cancer has completed.
-
FDA approval · 2021-05-19FDA Approved: KIT FOR THE PREPARATION OF LYMPHOSEEK (TECHNETIUM TC 99M TILMANOCEPT) — Supplemental Application (Cardinal Health 414, LLC)
FDA approved a supplemental application for the Kit for the Preparation of Lymphoseek (Technetium-99m Tilmanocept) to prepare Lymphoseek for…
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer [Phase 3]
Phase 3 trial update for a study in hormone-receptor positive locally advanced or metastatic breast cancer completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer. [EARLY_Phase 1]
A Phase 1 trial evaluating pembrolizumab (Keytruda) effects on biomarkers in early breast cancer, including triple-negative and hormone rece…
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant. [Phase 1]
Phase 1 trial evaluating breast cancer cells in premenopausal and postmenopausal women before and after exposure to tamoxifen or fulvestrant…
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases [Phase 2]
Phase 2 trial update of cabozantinib with or without trastuzumab in breast cancer patients with brain metastases has completed with results …
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: PREMs on PROMs in Breast Disease (PREMs_PROMs) [Phase 3]
Phase 3 clinical trial update for PREMs on PROMs in breast disease/ breast cancer completed.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating fulvestrant in combination with enzalutamide for ER+/HER2- advanced breast cancer has completed with results posted…
-
CLINICAL_TRIALS research · 2021-05-14Clinical Trial Update: Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D) [Phase 2]
Phase 2 trial evaluating safety, feasibility, and efficacy of vitamin D supplementation in women with metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer [Phase 4]
Phase 4 trial update on tilmanocept tracing and dynamics in early stage breast cancer, withdrew the study.
-
FDA label_change · 2021-05-12FDA Approved: FULVESTRANT — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Fulvestrant from Fresenius Kabi USA, LLC. The submission appears to concern a labeling-related u…